Cargando…
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
INTRODUCTION: The development of a human immunodeficiency virus 1 (HIV‐1) vaccine remains a formidable challenge. An effective vaccine likely requires the induction of broadly neutralizing antibodies (bNAbs), which likely involves the use of native‐like HIV‐1 envelope (Env) trimers at some or all st...
Autores principales: | Derking, Ronald, Sanders, Rogier W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606863/ https://www.ncbi.nlm.nih.gov/pubmed/34806305 http://dx.doi.org/10.1002/jia2.25797 |
Ejemplares similares
-
Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011) -
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017) -
Conjugation of a Toll‐Like Receptor Agonist to Glycans of an HIV Native‐Like Envelope Trimer Preserves Neutralization Epitopes
por: Li, Zeshi, et al.
Publicado: (2022) -
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
por: Derking, Ronald, et al.
Publicado: (2015) -
Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms
por: Brouwer, Philip J.M., et al.
Publicado: (2019)